We’re proud to be ranked first in M&A in Canada according to Bloomberg, as well as being the only Canadian firm ranked among the top 20 M&A advisers in the world.
Will a deal consolidating two Canadian cannabis companies serve as the final death knell for the poison pill?
Regulators not only blocked CanniMed’s attempted poison pill defending Aurora’s hostile bid—they also confirmed that hard lock-ups are a legitimate way for buyers to commit the target company’s shareholders to the hostile bid.
Our experts discuss defence tactics and more in this bulletin.
Ontario’s cap-and-trade system has now joined the carbon market in California and Québec. We discuss the changes that 2018 will bring.
Fast-moving cannabis companies have reaped the many rewards of having first-mover advantage, but it is now time to take a sober second look at broader business practices to ensure they are in line with similarly large and established players in other fields.
The pressing matter at hand? Playing catch-up with corporate governance. Our partner discusses the topic in this op-ed.
Read our expert team's recommendations.
How do courts treat tippees at various levels of the chain? We examine.
The SEC’s statement urges public companies to adopt comprehensive cybersecurity policies and procedures.